We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
-22.02%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$153M
AUM Growth
-$115M
Cap. Flow
-$44.1M
Cap. Flow %
-28.78%
Top 10 Hldgs %
74.73%
Holding
47
New
4
Increased
2
Reduced
12
Closed
7

Top Buys

Rank Stock Value
1
ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
+$9.47M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$4.34M
3
META icon
Meta Platforms (Facebook)
META
+$1.85M
4
ADVM
Adverum Biotechnologies
ADVM
+$1.06M
5
CMG icon
Chipotle Mexican Grill
CMG
+$951K

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$14.2M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$11.4M
3
CXRX
Concordia International Corp. Common Stock
CXRX
+$8.65M
4
AMZN icon
Amazon
AMZN
+$6.24M
5
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$6.17M

Sector Composition

Rank Sector Weight
1 Healthcare 60.96%
2 Consumer Discretionary 14.95%
3 Communication Services 13.93%
4 Financials 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$30.8M 20.11%
760,379
-97,300
-11% -$6.17M
META icon
2
Meta Platforms (Facebook)
META
$1.49T
$15M 9.82%
131,755
+17,569
+15% +$1.85M
SBUX icon
3
Starbucks
SBUX
$119B
$13.8M 8.99%
230,690
– –
AGN
4
DELISTED
Allergan plc
AGN
$11.8M 7.73%
44,189
– –
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$11.2M 7.28%
673,075
– –
BX icon
6
Blackstone
BX
$105B
$8.28M 5.4%
295,009
-412
-0.1% -$10.9K
ARLZ
7
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$6.52M 4.26%
+1,836,375
New +$9.47M
CXRX
8
DELISTED
Concordia International Corp. Common Stock
CXRX
$6.28M 4.1%
245,400
-289,400
-54% -$8.65M
AMZN icon
9
Amazon
AMZN
$2.46T
$5.54M 3.62%
186,780
-220,000
-54% -$6.24M
AVDL
10
DELISTED
Avadel Pharmaceuticals
AVDL
$5.24M 3.42%
474,439
-30,000
-6% -$298K
GOOG icon
11
Alphabet (Google) Class C
GOOG
$4.06T
$4.52M 2.95%
+121,280
New +$4.34M
LGND icon
12
Ligand Pharmaceuticals
LGND
$5.96B
$3.87M 2.53%
57,987
– –
INSY
13
DELISTED
Insys Therapeutics, Inc.
INSY
$3.54M 2.31%
221,538
-129,440
-37% -$2.46M
ALXN
14
DELISTED
Alexion Pharmaceuticals
ALXN
$3.54M 2.31%
25,424
-8,000
-24% -$1.17M
QLTI
15
DELISTED
QLT Inc
QLTI
$3.17M 2.07%
1,592,993
– –
WING icon
16
Wingstop
WING
$3.84B
$2.63M 1.72%
116,057
– –
BSTC
17
DELISTED
BioSpecifics Technologies Corp.
BSTC
$2.53M 1.65%
72,649
– –
JNP
18
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$2.17M 1.42%
328,132
– –
NFLX icon
19
Netflix
NFLX
$301B
$1.79M 1.17%
174,840
-1,450,000
-89% -$14.2M
IPXL
20
DELISTED
Impax Laboratories, Inc.
IPXL
$1.71M 1.12%
53,373
– –
ASRT
21
DELISTED
Assertio
ASRT
$1.64M 1.07%
1,965
-3,289
-63% -$3.05M
CBM
22
DELISTED
Cambrex Corporation
CBM
$1.55M 1.01%
35,148
-5,425
-13% -$214K
SGNT
23
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$1.24M 0.81%
101,630
– –
ADVM
24
DELISTED
Adverum Biotechnologies
ADVM
$982K 0.64%
+18,992
New +$1.06M
CMG icon
25
Chipotle Mexican Grill
CMG
$43.6B
$942K 0.62%
+100,000
New +$951K
1
2

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q1 2016 Portfolio in Review

As of Q1 2016, JW Asset Management held 47 positions worth $153M, down 43% from $268M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

JW Asset Management withdrew a net $44.1M in Q1 2016, closing 7 positions and reducing 12 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $11.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, down from 70% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, JW Asset Management opened a new position in Aralez Pharmaceuticals Inc. worth $6.52M.

  • JW Asset Management's largest Q1 2016 buy was Aralez Pharmaceuticals Inc.: 1,836,375 shares worth $6.52M.
  • JW Asset Management added most to Meta Platforms (Facebook) in Q1 2016, an estimated $1.85M increase.
  • JW Asset Management's biggest Q1 2016 reduction was Netflix, cutting an estimated $14.2M.
  • JW Asset Management fully exited Regeneron Pharmaceuticals in Q1 2016, selling an estimated $11.4M.
  • JW Asset Management's ten largest holdings make up 75% of its $153M portfolio in Q1 2016.
  • JW Asset Management opened 4 new positions and closed 7 in Q1 2016.
  • JW Asset Management's portfolio value fell 43% quarter-over-quarter to $153M.

Based on JW Asset Management's 13F filing for Q1 2016, filed 12 May 2016.